Sun Pharmaceuticals Industries Ltd. (SUNPHARMA) - Raw Materials Company raw materials « Mar 11 Mar 13 » Sun Pharma Inds. Live BSE, NSE Charts, historical charts, F&O Quote, Stock quote of Sun Pharma Inds., Sun Pharma Inds. News, Videos, Stock Market Reports, capitalisation, financial report, volume Annual Reports; Quarterly Reports; SEC Filings; 34 th Annual General Meeting ; Annual Report Subsidiary Financials. Download reports from archives Annual Report 2012 - 13. Annual Report Subsidiary Financials. Annual Report 2011 - 12. Striving for Leadership through Chemistry. We are using cookies to give you the best experience on our website. Accept Rediff MoneyWiz, the personal finance service from Rediff.com equips the user with tools and information in the form of graphs, charts, expert advice, and more to stay up-to-date and make informed decisions. Find a nice report by Ryan Williams, an ECS, who has joined us in Kyoto. Please remember to send us a quick email with your feedback to gro.e 1553860642 tamil 1553860642 c-cra 1553860642 ps@ec 1553860642 iffo 1553860642 . Annual Report - FY12-13 Download. Annual Report - FY11-12 Download. Annual Report - FY10-11 Hon'ble High Court of Hyderabad approved the merger of Auctus Pharma with Granules India : 13-11-2014: Download: Unpaid Dividend FY 2012-13. Download. Unpaid Dividend FY 2013-14. Download. Unpaid RSS stands for Really Simple Syndication. RSS feed is a XML file that provides summaries, including links to the full versions of the content.It is available through RSS feed reader or through some browsers. Sun Pharma Advanced Research Company Director Information - Get the latest information about Directors of Sun Pharma Advanced Research Company on The Economic Times 1,584 shares belonging to 13 shareholders were lying unclaimed in the aforesaid account. 2013, the Annual Report and the It is a broadly described annual report of Sun Pharmaceutical Industries Limited in the year of 2013-2014.During the financial year, The Company's Total Income Rs. 29,882 million. Net Profit after Tax for the year Rs. 28,285.2 million. QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) 2011 was derived from the Company's audited consolidated financial statements included in the 2011 Annual Report on Form 10-K. On February 17, 2012, through Par Pharmaceutical, Inc., our wholly-owned subsidiary, we completed our 2012-13_Annual_Report-SPIL. Internal controls sun pharmas defined organizational Lab Report. Uploaded By Professor_Moon_Dragon15. Pages 132 This preview shows pages 33-37. Sign up to view the full content. INTERNAL CONTROLS 2012-13_Annual_Report-SPIL. Internal controls sun pharmas defined organizational Lab Report. Uploaded By Professor_Moon_Dragon15. Pages 132 This preview shows pages 33-37. Sign up to view the full content. INTERNAL CONTROLS